Improving screening and treatment for latent tuberculosis
A New Approach to an Old Problem: Redesigning Latent Tuberculosis Screening and Treatment
This study is looking to make it easier and better for people in California to get tested and treated for latent tuberculosis infection (LTBI), so they can stay healthy and help reduce the number of TB cases in the community.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-10798335 on NIH RePORTER |
What this research studies
This research aims to enhance the screening and treatment processes for latent tuberculosis infection (LTBI) in California, where TB cases are notably high. By analyzing electronic health records from major healthcare institutions and gathering insights from stakeholders, the project will identify gaps in current screening practices and treatment guidelines. The research will also simulate ideal screening scenarios to estimate the potential reduction in TB cases. Ultimately, the goal is to improve patient care and increase treatment completion rates for those with LTBI.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in California who are at risk for latent tuberculosis infection.
Not a fit: Patients who are not at risk for latent tuberculosis or those who have already been treated for active TB may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective screening and treatment strategies for latent tuberculosis, potentially reducing the incidence of active TB cases.
How similar studies have performed: Previous research has shown that improving screening and treatment protocols can significantly reduce the incidence of tuberculosis, indicating that this approach has potential for success.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Tartof, Sara — Kaiser Foundation Research Institute
- Study coordinator: Tartof, Sara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.